Chronic Cutaneous Lupus Erythematosus (CCLE)
Chronic cutaneous lupus erythematosus (CCLE/CLE) is a group of chronic autoimmune diseases confined to the skin. Of its subtypes, discoid lupus erythematosus (DLE) is the most common, and it is a leading cause of permanent scarring hair loss on the scalp if it is not treated in time.
Hair loss in chronic cutaneous lupus results from a complex interplay of genetics, a cell-mediated autoimmune response, and ultraviolet (UV) light:
- Interface inflammation (interface dermatitis): Autoreactive T cells (mainly CD4+ and CD8+) pour into the junction between the epidermis and dermis and around the pilosebaceous unit. This causes vacuolar degeneration of the basal cells lining the hair follicle.
- Destruction of follicular stem cells in the bulge region: The autoimmune attack targets the follicular bulge, where the hair follicle stem cells live. Once these stem cells are wiped out by apoptosis (programmed cell death), the follicle can no longer regrow a hair, and the result is permanent scarring hair loss (cicatricial alopecia).
- UV radiation as a trigger: UV light causes widespread death of keratinocytes, exposing autoantigens (such as Ro/SSA, La/SSB, and HMGB1) on the cell surface. This activates plasmacytoid dendritic cells, which release large amounts of interferon-alpha (IFN-alpha) and keep a chronic inflammatory loop going.
- Immune complex and mucin deposits: Antibodies (IgM, IgG) and complement (C3) are deposited along the follicular basement membrane, forming the lupus band. At the same time, mucin builds up in the dermis, compressing, scarring, and badly distorting the structure of the scalp dermis.
At Haute-Derma, we treat hair loss from DLE/CLE as an urgent restorative case. We move quickly to confirm the diagnosis with a biopsy and immunofluorescence so we can halt follicle destruction before the scarred patches spread.
Clinical Features and Differential Diagnosis
Discoid lupus (DLE) of the scalp has characteristic features at each stage:
- The classic clinical triad of DLE:
- Redness and red papules (erythema): Early on, there are firm, well-defined, slightly raised red plaques that may itch, sting, or feel mildly sore.
- Scale and follicular plugging (follicular hyperkeratosis and plugging): Adherent scale plugs the hair follicle openings. When the scale is gently lifted with tweezers, its underside shows sharp keratin spikes pointing downward like tacks. This is the carpet tack sign (Besnier's sign), which is highly characteristic of DLE.
- Atrophy, scarring, and pigment change (dyschromia): Later, the lesion becomes a shiny white atrophic patch in the center with no follicle openings left, while the edge often shows gray-brown hyperpigmentation or patchy loss of pigment.
- Trichoscopy findings (detailed scalp dermoscopy):
- Large keratotic plugs: Yellow or gray-brown keratin masses blocking the follicle openings.
- Arborizing vessels (thick red branching lines): A network of dilated, tree-like capillaries around the inflamed area.
- Follicular red dots: A sign of vessel dilation and active inflammation around the follicular opening.
- Smooth white scarred areas: Follicle openings are completely gone, replaced by fibrous tissue.
How Haute-Derma Diagnoses and Treats the Condition
- Histopathology and direct immunofluorescence (DIF): The doctor uses trichoscopy to find areas that are still actively inflamed, then takes a 4 mm scalp punch biopsy from the advancing edge of the bald patch:
- H&E staining: Looks for vacuolar degeneration of the basal layer, lymphocytes around follicles and blood vessels, and a thickened basement membrane.
- Alcian blue staining: Confirms mucin deposition in the dermis.
- Direct immunofluorescence (DIF, lupus band test): Detects a continuous granular band of IgG, IgM, and C3 along the basement membrane.
- Systemic screening: ANA (antinuclear antibodies), anti-dsDNA, and anti-Ro/SSA tests to rule out systemic lupus erythematosus (SLE) with skin involvement.
- Comprehensive medical treatment:
- Synthetic antimalarials: Oral hydroxychloroquine (HCQ) at 5 mg/kg of actual body weight per day. It modulates the immune system, reduces IFN-alpha production, and dampens photosensitivity reactions.
- Topical and intralesional corticosteroids (ILTAC): Super-potent topical corticosteroids (clobetasol propionate) or triamcinolone acetonide injected directly into the edge of the plaque to settle acute inflammation quickly.
- Topical calcineurin inhibitors (tacrolimus / pimecrolimus): Used instead of, or alternating with, corticosteroids for long-term maintenance, avoiding steroid-related skin thinning and vessel dilation.
- Strict sun protection and scalp care: Patients must follow strict photoprotection: broad-spectrum sunscreen (SPF 50+, PA++++) and a wide-brimmed, UV-protective hat outdoors. Gentle shampoos without harsh detergents help protect the damaged scalp barrier.
Comparing the Forms of Lupus That Affect the Hair
| Type of Lupus | Type of Hair Loss | Clinical Features & Outlook |
|---|---|---|
| Discoid lupus erythematosus (DLE, CCLE) | Scarring alopecia | Atrophic DLE plaques with "carpet tack" scale and loss of follicle openings. Once scarring has formed, the damage is permanent. |
| Subacute cutaneous lupus erythematosus (SCLE) | Non-scarring alopecia | Annular or psoriasis-like (papulosquamous) skin lesions. Diffuse, temporary shedding that can regrow once the disease is controlled. |
| Systemic lupus erythematosus (SLE) | Lupus hair and diffuse hair loss | Diffuse thinning (telogen effluvium) or dry, short, easily broken hairs along the frontal hairline ("lupus hair"). Hair grows back fully once SLE goes into remission. |
